Rate My Professor Damion Corrigan

As founding Director and Chief Scientific Officer of Aureum Diagnostics, he advances low-cost electrochemical assay platforms for biosafety and biopharmaceutical applications. He is also co-founder and Chief Technology Officer of Microplate Dx, specializing in rapid diagnostic tools for antibiotic susceptibility testing. Corrigan's interdisciplinary efforts involve collaborations with clinicians, microbiologists, engineers, and industry partners including GSK, AstraZeneca, the National Nuclear Laboratory, and SMEs. A Fellow of the Royal Society of Chemistry (FRSC), he co-chairs the Measurement Science Institute for CAMS-UK and serves on the UKRI Interdisciplinary Assessment College, National Physical Laboratory Industrial Committee on Biosensors, and Scottish Pandemic Sciences Partnership Oversight Board. Awards include Academic Entrepreneur of the Year at the PraxisAuril Knowledge Exchange Awards (2023), Royal Society of Chemistry Analytical Section Mid Career Prize (2025), and multiple accolades for Microplate Dx such as Startup of the Year (Barclays Entrepreneur Awards, 2023). Key publications comprise 'Development of a high-sensitivity electrochemical immunoassay using a fully 3D-printed electrocatalytic microelectrode probe platform' (Analytical Chemistry, 2026), 'WAFFLE – an automated platform for enhancing the performance of electrochemical biosensors' (Lab on a Chip, 2026), 'Towards enhanced selection of antibiotics in a hospital laboratory development of a rapid electrochemical-based antimicrobial sensitivity test for Urinary Tract Infections' (ACS Sensors, 2026), and 'Maximising the translation potential of electrochemical biosensors' (Chemical Communications, 2025). He leads modules in Cell Biology, Biophysical Chemistry, Biotechniques, Analytical Chemistry, and Medical Diagnostics.